drugset / Trial / NCT05684952
The Efficacy and Safety of a Chinese Herbal Medicine for Long COVID Associated Fatigue
Phase 2
Unknown
152 enrolled
Hong Kong Baptist University
Jiangzhong Pharmaceutical Co., Ltd. · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
This is a randomized, double-blinded, placebo-controlled clinical trial to determine the efficacy and safety of a Chinese herbal medicine (Shenlingcao oral liquid) for treating long COVID associated fatigue.
Timeline
- Start
- 2023-05-30
- Primary completion
- 2024-01-15
- Completion
- 2024-02-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Shenlingcao Oral Liquid | Traditional medicine (herbal / TCM) | 200 ml | Oral |